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We present two siblings affected with opsismodysplasia (OPS), a rare skeletal dysplasia 
caused by mutations in the inositol polyphosphate phosphatase-like 1 gene. The skeletal 
findings include short stature with postnatal onset micromelia, marked platyspondyly, 
squared metacarpals, delayed skeletal ossification, metaphyseal cupping, and postnatal 
micromelia. Respiratory compromise, delayed ambulation, and progressive lower extremity 
deformities are described. The severity of findings is variable. Renal phosphate wasting 
is associated with severe bone demineralization and a more severe phenotype. This 
report represents the first described cases of opsismodysplasia treated with intravenous 
bisphosphonate (pamidronate). Surgical management for lower extremity deformities 
associated with OPS is also reviewed.
Level of Evidence: IV Case series
Keywords: opsismodysplasia, metabolic bone disease, skeletal dysplasias, scoliosis, genu varum, bisphosphonates
introduction
Opsismodysplasia (OPS) is a rare autosomal recessive skeletal dysplasia associated with delayed 
bone maturation and micromelia (1, 2). Maroteaux et al. originally coined the term in 1984 (3). 
The most frequent clinical signs evident at birth are relative macrocephaly with a large anterior 
fontanelle, craniofacial abnormalities including a prominent brow, depressed nasal bridge, a 
small anteverted nose, and a relatively long philtrum, abdominal protrusion, and hypotonia 
(4–6). The main radiological features are severe platyspondyly, short long bones including squared 
metacarpals, delayed epiphyseal ossification, and metaphyseal flaring and cupping (7–10). 
Square iliac wings with horizontal acetabular roof and ossification defect at the skull base are also 
seen (11).
Opsismodysplasia can be associated with renal phosphate wasting (12). Mutations in the inositol 
polyphosphate phosphatase-like 1 (INPPL1) gene were recently identified to be a cause OPS (5, 
9, 13). The two patients in this case report were diagnosed with opsismodysplasia based on their 
clinical and radiographic findings. Their diagnosis was confirmed on molecular analysis. The 
older sibling had findings of renal phosphate wasting. Both were treated with a bisphosphonate 
(pamidronate). This case series adds to the current literature on this rare condition with a clinical 
description of our two patients, documenting their surgical management as well as their response 
to bisphosphonate therapy. Our study is IRB approved (12259) and the patient’s family gave full 
consent.
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Case 1
The first patient is a male who was initially evaluated at 14 months 
of age for a skeletal dysplasia. He was referred to the genetics 
clinic because of his short stature, and presented with a relatively 
large orbitofrontal cortex and fontanelle but no other chronic 
medical illnesses. Radiographs from a skeletal survey obtained 
at 14 months of age revealed short tubular bones with delayed 
epiphyseal ossification and metaphyseal cupping (Figure 1), shal-
low acetabulae with bilateral hip subluxation, and short femoral 
necks with metaphyseal irregularity. There was also frontal bossing 
in the skull and diffuse osteopenia. At follow up at 16 months of 
age his height and weight were at the fifth percentile (64.2 cm and 
Figure 1 | Case 1, aP view of right hand demonstrates delayed 
carpal ossification, shortened phalanges and metacarpals, and 
metaphyseal cupping at (a) 14 months of age, (B) at 3 years 5 months 
of age with decreased bone mineralization and (C) at 4 years 
4 months of age following pamidronate therapy. Note the bowing of the 
distal radius and ulna.
7.9 kg). He had a large and soft anterior fontanelle for his age, a 
depressed nasal bridge and prominent forehead. He was unable 
to fully extend his elbows and had bilateral anterolateral tibial 
bowing. His abdomen was soft without organomegaly.
At 2  years of age his head circumference was in the 75th 
percentile (49.8  cm), with height at 5th percentile (69.1  cm) 
and weight at 5th percentile (8.72  kg), reinforcing the previ-
ously described phenotype of relative macrocephaly without 
hydrocephalus. His examination revealed volar subluxation of 
the carpus, and a sharp bow of the distal radius. He lacked 30° 
of elbow extension. There was similar bowing at the distal end 
of tibia with the foot subluxated posteriorly. He had limited hip 
abduction to 40° bilaterally and full knee extension. He did not 
have significant kyphosis or scoliosis, but a somewhat barrel-
shaped chest. Calcium and magnesium levels were normal, but 
phosphate was low (2.0 mg/dl).
Initial skeletal survey revealed diffuse cervical, thoracic, and 
lumbar platyspondyly without significant scoliosis or kyphosis. 
Repeat skeletal survey at 2 years and 10 months of age (9/19/05) 
and again at 3  years and 5  months (4/10/06) demonstrated 
marked platyspondyly (Figure 2) and also demonstrated more 
severe, now marked osteopenia and new tapered appearance of 
the proximal metacarpals, distal radius and ulna, and femoral 
necks. Periosteal reaction was present along the shafts of the left 
humerus, radius, and ulna, without discrete fracture lines. There 
was continued significant delay in epiphyseal ossification, with 
none present at the hips, shoulders, elbows, and carpal rows. 
Dedicated radiographs of the left tibia and fibula demonstrated 
anterior convex bowing of the distal leg with associated tapered 
appearance of metadiaphyses, and no significant distal epiphyseal 
ossification (Figure  3). There was also very poor midfoot and 
hindfoot ossification (3/14/05 tib fib).
At approximately 2½  years of age, the patient developed 
progressive respiratory failure secondary to his skeletal dysplasia 
and was started on supplemental oxygen. He was identified to 
have cardiomegaly with enlargement of the left ventricle. He was 
found to have a  hypoplastic right kidney. His bone age was severely 
delayed and estimated at between 0 and 3 months of age. Dual 
x-ray absorptiometry (DXA) scan at this point showed severe 
demineralization of bones, and was he was started on pamidronate 
for his osteoporosis. He received 0.5 mg/kg/IV infusion on each 
of 3 days, given sequentially. At 3 years of age, he underwent a 
tracheostomy and required mechanical ventilatory support for 
progressive respiratory failure. A gastrostomy-tube was placed 
for nutritional support.
After the first pamidronate infusions (two sets of 3  day 
infusions), whole-body bone mineral density was increased by 
11.6% and total lumbar spine bone mineral density showed a 
26.9% increase. He continued to receive pamidronate infusions 
quarterly at 9 mg/kg/year and undergoing DXA scans annually. 
(Table 1) At 4 years of age, with the noted clinical improvement 
and reversal in his deteriorating pulmonary function associated 
with his pamidronate infusions, he started limited ambulation. He 
was provided with physical therapy services. At 5½ years old, he 
was able to take six steps independently and 20–30 steps with a 
walker. At 6 years, he was able to walk 15–20 feet independently. He 
underwent bilateral Sofield osteotomies of the tibiae to straighten 
Figure 3 | Case 1, (a) lateral view of tibia demonstrates initial poor 
mineralization and irregularity of the distal tibial metaphysis with 
anterior bowing at 2 years 4 months of age, (B) with improved 
mineralization but persistent bowing at age 4 years 4 months and  
(C) subsequent osteotomy and intramedullary pin placement at 
8 years 7 months.
Figure 2 | Case 1, (a) lateral spine shows marked platyspondyly at 
3 years 5 months, (B) which improves on follow up films at 7 years 
6 months of age.
taBle 1 | Patient 1 bone mineral density.
age  
(years)
Whole body  
(g/cm2)
Z-score lumbar  
(g/cm2)
Z-score left hip bone  
(g/cm2)
Z-score right Femur  
(r1) (g/cm2)
Z-score
4 0.505 −3.1 0.162 −6.3 0.459
6 0.527 −3.2 0.147 −6.7 0.392 −3.4 0.352 −3.4
7a 0.619 −1.8 0.198 −5.9 0.350 −3.4
8 0.609 −2.6 0.201 −5.8 0.382 −4.1 0.327 −3.3
9 0.580 −3.6 0.317 −4.0 0.490 −2.9 0.382 −3.1
10 0.659 +0.5 0.804 +0.5 0.482 −2.5
a S/P bilateral Sofield osteotomies.
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his legs at 6 years of age. With this procedure, he had a 3-month 
pause in his pamidronate infusions. At 8½ years, he was walking 
100 feet at school with a walker. At 9 years his pamidronate infusion 
was reduced to 1 mg/kg/infusion twice yearly. At 10 years of age, 
he has stopped taking his wheelchair to school and runs during 
recess, demonstrating a remarkable progress presumably related 
to his pamidronate usage.
His diagnosis of opsismodysplasia was recently confirmed by 
exome sequencing analysis. He was identified to have homozy-
gosity for a missense mutation in exon 17 of the INPPL-1 gene 
(c.1976C > T).
Case 2
The younger sibling of the patient in Case 1 also had clinical, 
radiological, and molecular findings consistent with a diagnosis 
of opsismodysplasia. She was born at 38 weeks via C-section and at 
9 days of life presented with respiratory distress and a right-sided 
pneumothorax. She was discovered to have a large atrial septal 
defect (ASD). Because of her brother’s skeletal dysplasia, she was 
evaluated for the diagnosis of opsismodysplasia. Radiographically, 
no secondary ossification centers were identified, specifically to 
include the proximal tibial and distal femoral epiphyses, which 
should be present at this age. (Figure  4) The metacarpals and 
phalanges of her hands and feet were shortened with metaphyseal 
cupping. Platyspondyly was present and the symphysis pubis was 
Figure 4 | Case 2, initial skeletal survey at 9 days of life (a) [10/09/08] 
demonstrates lack of visualization of the distal femoral and proximal 
tibial ossification centers, (B) relatively short long bones of the left 
upper extremity and (C) feet with metaphyseal cupping and irregular 
ossification of the talus and calcaneus. The degree of platyspondyly (d) 
is less than that of her sibling on lateral spine radiographs.
Figure 5 | standing frontal projection of bilateral lower extremities 
(a) at age 3 years and 2 months (12/05/11) demonstrates bilateral 
genu varum, which was treated with bilateral lateral 
hemiepiphysiodesis plate and screws (B) of the proximal tibia, as 
shown on the right in.
taBle 2 | Patient 2 bone mineral density.
age  
(years)
Whole body  
(g/cm2)
Z-score lumbar  
(g/cm2)
Z-score left hip bone  
(g/cm2)
Z-score right femur  
(r1) (g/cm2)
Z-score
1/2a 0.168 0.289
1a 0.213 0.223
2 0.474 0.485
3 0.605 +2.9 0.671 0.672 1.3
4 0.702 +2.4 0.665 +3.0 0.683 0.643 +0.3
a Limited lumbar spine BMD.
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identified to have scoliosis with a 42° right thoracic curve, and a 
57° left lumbar curve. She developed a mild bilateral genu varum 
deformity by age three and still had lack of ossification of the 
proximal femoral. (Figure 5) Cervical spine films show odontoid 
hypoplasia, with no evidence of atlantoaxial or occipitocervical 
instability. She had continued diffuse platyspondyly with anterior 
pointing of the vertebral bodies.
A follow-up DXA scan at approximately 3  years of age 
revealed her lumbar spine bone mineral density to be normal. 
Her pamidronate infusions were reduced to once every 6 months 
for a dose of 2 mg/kg/year. At 4 years, she had significant genu 
varum and underwent placement of lateral proximal tibial growth 
modulation plates. She continues to have normal to increased bone 
mineral density compared with the reference population. Exome 
sequencing for this child also revealed homozygosity for a missense 
mutation in exon 17 of the INPPL1 gene (c.1976C > T).
discussion
We present two siblings with OPS who presented with variability 
in their clinical and radiographic findings. Both were identified 
to have homozygosity for a missense mutation in exon 17 of 
the INPPL1 gene (c.1976C >  T). The clinical presentation and 
radiographic findings in Patient 1 were much more severe. He 
had phosphate wasting, progressive bony demineralization, and 
poorly ossified. Her talus and calcaneus were ossified, but irregular 
in shape. Her ribs were mildly shortened with cupped anterior rib 
ends. Her serum phosphorous was normal.
At the age of 9 days, on physical examination she measured 
48 cm (25th–50th percentile), weighed 3.06 kg (25th percentile), 
and had a head circumference of (of 36.5 cm (75th percentile). 
Her anterior fontanelle was flat and soft and measured 5.5 × 6.0 
(greater than 90th percentile). At 9 months her length was 62 cm 
and her weight 6.3 kg. These are both below the third percentile for 
her age. She was also diagnosed with restrictive lung disease, and 
she had a gastrostomy-tube placed because of feeding difficulties. 
Her head circumference at 13 months however, was 90th percentile 
while her height and weight remained at below the third percentile.
A DXA scan was performed at 1 year and revealed diminished 
bone mineral density of the left femur (0.334–0.326 g/cm2) from 
her 5-month scan (no Z scores available because of age – Table 2). 
Because of her decreased mineral density, she was started on 
pamidronate at a dose of 0.5 mg/kg/infusion for a total of 9 mg/
kg/year pamidronate. She was standing and walking at 2 years of 
age. She had slight anterolateral bowing of her distal tibias. She was 
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respiratory failure. Both patients’ clinical presentations are largely 
in accordance with the literature. Their facial features were con-
sistent with those described in OPS, including a prominent brow, 
relative macrocephaly with a large anterior fontanel, depressed 
nasal bridge, anteverted nose, and a long philtrum (4–6). Both had 
short limbs, lower extremity deformity, and small hands and feet. 
They also developed respiratory complications, as has also been 
reported in the literature (6). Patient 1 was more severely affected, 
which we hypothesize was related to his phosphate wasting. His lack 
of treatment until a later age is another possible contributory factor.
On radiographs, our patients corroborate the literature, which 
reports delayed epiphyseal ossification, platyspondyly, metaphy-
seal cupping, and short metacarpals and phalanges (7–10). Both 
patients had anterolateral bowing of the tibias, patient 1 requiring 
surgical intervention. These cases provide evidence of the vari-
ability in severity of findings in siblings with opsismodysplasia 
and suggest that those with phosphate wasting have more severe 
skeletal findings and respiratory compromise. Both of our patients 
also had difficulty feeding, which is not reported in the literature 
to date. This is the first known report of pamidronate therapy 
for opsismodysplasia, and the surgical management of the lower 
extremity deformities associated with this disorder.
As with other disorders, such as polyostotic fibrous dysplasia, 
we found with these two patients that phosphate wasting is associ-
ated with a poorer outcome. Both patients demonstrated clinical 
progress and improvement in bone mineral density measured 
using serial DXA scan studies with pamidronate therapy. Surgical 
correction by osteotomy appears to have lasting results. It is too 
soon to determine whether growth modulation techniques will 
be of benefit in patient 2. 
Surgical management of these patients mirrored treatment 
well described for other metabolic bone disorders such as 
osteogenesis imperfecta and rickets.  When enough growth is 
available, guided growth techniques may be appropriate, although 
the ultimate outcome of patient 2 is still pending. For the more 
complex deformities seen in patient 1, single level, or in this case, 
multi-level Sofield realignment osteotomies may be required. Our 
patient ultimately began to grow off the William’s rod that was 
used, so the use of newer generation telescoping rods may now 
present a better option in these circumstances. Another interesting 
technical note is that due to the poor ossification of the metaphyses 
and epiphyses, location of the rod ends can be challenging with 
fluoroscopy.
summary
In summary, we describe two siblings diagnosed with opsismod-
ysplasia based on clinical and radiographic findings, confirmed by 
genetic analysis. The older sibling had a more severe clinical course 
and renal phosphate wasting. His significant associated lower 
extremity deformities were corrected with Sofield osteotomies. 
After 7 years of pamidronate therapy, he no longer requires daytime 
ventillatory support and his ambulatory function has improved 
such that he requires no longer requires assistive devices.
The younger sibling’s showed no signs of urine phosphate 
wasting. Due to her diagnosis and low bone mineral density, 
she was initiated on pamidronate at the age of 1 year. Her bone 
mineral density has normalized when compared to the reference 
population. She has genu varum that is currently being treated 
with growth modulation plates.
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